<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35421963</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan.</ArticleTitle><Pagination><StartPage>757</StartPage><MedlinePgn>757</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">757</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-022-13169-x</ELocationID><Abstract><AbstractText Label="BACKGROUND">Concerns have grown that post-acute sequelae of COVID-19 may affect significant numbers of survivors. However, the analyses used to guide policy-making for Australia's national and state re-opening plans have not incorporated non-acute illness in their modelling. We, therefore, develop a model by which to estimate the potential acute and post-acute COVID-19 burden using disability-adjusted life years (DALYs) associated with the re-opening of Australian borders and the easing of other public health measures, with particular attention to longer-term, post-acute consequences and the potential impact of permanent functional impairment following COVID-19.</AbstractText><AbstractText Label="METHODS">A model was developed based on the European Burden of Disease Network protocol guideline and consensus model to estimate the burden of COVID-19 using DALYs. Data inputs were based on publicly available sources. COVID-19 infection and different scenarios were drawn from the Doherty Institute's modelling report to estimate the likely DALY losses under the Australian national re-opening plan. Long COVID prevalence, post-intensive care syndrome (PICS) and potential permanent functional impairment incidences were drawn from the literature. DALYs were calculated for the following health states: the symptomatic phase, Long COVID, PICS and potential permanent functional impairment (e.g., diabetes, Parkinson's disease, dementia, anxiety disorders, ischemic stroke). Uncertainty and sensitivity analysis were performed to examine the robustness of the results.</AbstractText><AbstractText Label="RESULTS">Mortality was responsible for 72-74% of the total base case COVID-19 burden. Long COVID and post-intensive care syndrome accounted for at least 19 and 3% of the total base case DALYs respectively. When included in the analysis, potential permanent impairment could contribute to 51-55% of total DALYs lost.</AbstractText><AbstractText Label="CONCLUSIONS">The impact of Long COVID and potential long-term post-COVID disabilities could contribute substantially to the COVID-19 burden in Australia's post-vaccination setting. As vaccination coverage increases, the share of COVID-19 burden driven by longer-term morbidity rises relative to mortality. As Australia re-opens, better estimates of the COVID-19 burden can assist with decision-making on pandemic control measures and planning for the healthcare needs of COVID-19 survivors. Our estimates highlight the importance of valuing the morbidity of post-COVID-19 sequelae, above and beyond simple mortality and case statistics.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Angeles</LastName><ForeName>Mary Rose</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Institute for Health Transformation, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deakin Health Economics, School of Health and Social Development, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanni Arachchige Dona</LastName><ForeName>Sithara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Health Transformation, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deakin Health Economics, School of Health and Social Development, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Huong Dieu</ForeName><Initials>HD</Initials><AffiliationInfo><Affiliation>Institute for Health Transformation, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deakin Health Economics, School of Health and Social Development, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Long Khanh-Dao</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Institute for Health Transformation, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deakin Health Economics, School of Health and Social Development, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health economics Division, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hensher</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Health Transformation, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia. m.c.hensher@utas.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deakin Health Economics, School of Health and Social Development, Faculty of Health, Deakin University, 221 Burwood highway, Burwood, Victoria, 3125, Australia. m.c.hensher@utas.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Menzies Institute for Medical Research, University of Tasmania, Medical Science Precinct, 17 Liverpool Street, Hobart, Tasmania, 7000, Australia. m.c.hensher@utas.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657744">postintensive care syndrome</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019057" MajorTopicYN="N">Quality-Adjusted Life Years</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Australia</Keyword><Keyword MajorTopicYN="N">Burden of disease</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">DALY</Keyword><Keyword MajorTopicYN="N">Disability-adjusted life years</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">Post-acute COVID</Keyword></KeywordList><CoiStatement>Authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>5</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35421963</ArticleId><ArticleId IdType="pmc">PMC9009167</ArticleId><ArticleId IdType="doi">10.1186/s12889-022-13169-x</ArticleId><ArticleId IdType="pii">10.1186/s12889-022-13169-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duckett S, Wood D, Coates B, Mackey W, Crowley T, Stobart A. Race to 80: our best shot at living with COVID: Grattan Institute. 2021.</Citation></Reference><Reference><Citation>Kompas T, Grafton RQ, Che TN, Chu L, Camac J. Health and economic costs of early and delayed suppression and the unmitigated spread of COVID-19: the case of Australia. PLoS One. 2021;16(6):e0252400. doi: 10.1371/journal.pone.0252400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0252400</ArticleId><ArticleId IdType="pmc">PMC8177447</ArticleId><ArticleId IdType="pubmed">34086731</ArticleId></ArticleIdList></Reference><Reference><Citation>Duckett S, Stobart A. Australia&#x2019;s COVID-19 response: the story so far: Grattan Institute. 2020.</Citation></Reference><Reference><Citation>Department of Health . Government response to the COVID-19 outbreak: Department of Health. 2021.</Citation></Reference><Reference><Citation>Department of the Prime Minister and Cabinet . National Plan to transition Australia&#x2019;s National COVID-19 Response (July 2021) Australia. 2021.</Citation></Reference><Reference><Citation>Doherty Institute . Doherty modelling interim report to National Cabinet 17th September 2021 Australia: Doherty Institute. 2021.</Citation></Reference><Reference><Citation>Hensher M, Angeles MR, de Graaf B, Campbell J, Athan E, Haddock R. Deeble Institute issues brief no 40. Managing the long term health consequences of COVID-19 in Australia Canberra, Australia: Australian Healthcare and Hospitals Association; 2021; Cited 2021 August 01. Available from: https://ahha.asn.au/news/long-term-health-consequences-covid-19-can-value-based-health-care-provide-way-forward.</Citation></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyper G, Assun&#xe7;&#xe3;o R, Colzani E, Grant I, Haagsma JA, Lagerweij G, et al. Burden of disease methods: a guide to calculate COVID-19 disability-adjusted life years. Int J Public Health. 2021;66:4. doi: 10.3389/ijph.2021.619011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ijph.2021.619011</ArticleId><ArticleId IdType="pmc">PMC8565264</ArticleId><ArticleId IdType="pubmed">34744580</ArticleId></ArticleIdList></Reference><Reference><Citation>European Burden of Disease Network . Burden of disease of COVID-19: Protocol for country studies. 2020.</Citation></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders&#x2019; conference. Crit Care Med. 2012;40(2):502&#x2013;509. doi: 10.1097/CCM.0b013e318232da75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318232da75</ArticleId><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Bureau of Statistics . Table 1.9 Life Tables, Australia, 2017-2019. Canberra: ABS; 2020.</Citation></Reference><Reference><Citation>World Health Organization. The Global Burden of Disease concept The Global Burden of Disease concept; Cited 2021 August 01. 27-40]. Available from: https://www.who.int/quantifying_ehimpacts/publications/en/9241546204chap3.pdf.</Citation></Reference><Reference><Citation>Global Burden of Disease Collaborative Network . Global Burden of Disease Study 2019 (GBD 2019) Results Seattle, United States: Institute for Health Metrics and Evaluation (IHME) 2020.</Citation></Reference><Reference><Citation>Department of Health . Coronavirus (COVID-19) case numbers and statistics Australia. 2021.</Citation></Reference><Reference><Citation>Cuschieri S, Calleja N, Devleesschauwer B, Wyper GMA. Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year. BMC Public Health. 2021;21(1):1827. doi: 10.1186/s12889-021-11893-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11893-4</ArticleId><ArticleId IdType="pmc">PMC8501913</ArticleId><ArticleId IdType="pubmed">34627228</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021: Estimates of the prevalence of self-reported &#x201c;long COVID&#x201d;, and the duration of ongoing symptoms following confirmed coronavirus infection, using UK Coronavirus (COVID-19) Infection Survey data to 6 March 2021. UK: ONS; 2021; Cited 2021 September 01. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021.</Citation></Reference><Reference><Citation>Liu B, Jayasundara D, Pye V, Dobbins T, Dore GJ, Matthews G, et al. Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia. Lancet Region Health-Western Pacific. 2021;12:100193. doi: 10.1016/j.lanwpc.2021.100193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100193</ArticleId><ArticleId IdType="pmc">PMC8225991</ArticleId><ArticleId IdType="pubmed">34189493</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseau A-F, Minguet P, Colson C, Kellens I, Chaabane S, Delanaye P, et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann Intensive Care. 2021;11(1):1&#x2013;9. doi: 10.1186/s13613-021-00910-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00910-9</ArticleId><ArticleId IdType="pmc">PMC8319705</ArticleId><ArticleId IdType="pubmed">34324073</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care. 2010;14(1):R6&#x2013;RR. doi: 10.1186/cc8848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8848</ArticleId><ArticleId IdType="pmc">PMC2875518</ArticleId><ArticleId IdType="pubmed">20089197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofhuis JG, Schrijvers AJ, Schermer T, Spronk PE. Health-related quality of life in ICU survivors&#x2014;10 years later. Sci Rep. 2021;11(1):1&#x2013;10. doi: 10.1038/s41598-021-94637-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94637-z</ArticleId><ArticleId IdType="pmc">PMC8313552</ArticleId><ArticleId IdType="pubmed">34312447</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes J, Ball J, Gao L, Kai Chan Y, Kularatna S, Stewart S, et al. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial. J Med Econ. 2019;22(9):945&#x2013;952. doi: 10.1080/13696998.2019.1631831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13696998.2019.1631831</ArticleId><ArticleId IdType="pubmed">31190590</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Collaborative Network . Global Burden of Disease Study 2019 (GBD 2019) Disability Weights Seattle, United States: Institute for Health Metrics and Evaluation (IHME) 2020.</Citation></Reference><Reference><Citation>Doherty Institute . Modelling definitions and frequently asked questions. 2021.</Citation></Reference><Reference><Citation>Byambasuren O, Cardona M, Bell K, Clark J, McLaws M-L, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. Official J Assoc Med Microbiol Infect Dis Canada. 2020;5(4):223&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9602871</ArticleId><ArticleId IdType="pubmed">36340059</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin C, Luteijn M, Letton W, Robertson J, McDonald S. A model framework for projecting the prevalence and impact of long-COVID in the UK. PLoS One. 2021;16(12):e0260843. doi: 10.1371/journal.pone.0260843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260843</ArticleId><ArticleId IdType="pmc">PMC8639065</ArticleId><ArticleId IdType="pubmed">34855874</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43-55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Yu KF. What&#x2019;s the relative risk?A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690&#x2013;1691. doi: 10.1001/jama.280.19.1690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.280.19.1690</ArticleId><ArticleId IdType="pubmed">9832001</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078&#x2013;1087. doi: 10.1001/jamacardio.2021.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2065</ArticleId><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini A, Torrigiani A, Sbaragli S, Lo Forte A, Crociani A, Cecchini P, et al. COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge. Infection. 2021;49(5):1007&#x2013;1015. doi: 10.1007/s15010-021-01638-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01638-1</ArticleId><ArticleId IdType="pmc">PMC8179958</ArticleId><ArticleId IdType="pubmed">34091869</ArticleId></ArticleIdList></Reference><Reference><Citation>Health F. A detailed study of patients with long-haul COVID. 2021.</Citation></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz MM, Arias &#xc1;, Mata-V&#xe1;zquez E, Mart&#xed;n-Toledano M, L&#xf3;pez-Larramona G, Ruiz-Chicote AM, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10(13):2945. doi: 10.3390/jcm10132945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132945</ArticleId><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Cao Y. Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients? Diabetes Metab Syndr. 2021;15(1):147&#x2013;148. doi: 10.1016/j.dsx.2020.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.12.024</ArticleId><ArticleId IdType="pmc">PMC7737525</ArticleId><ArticleId IdType="pubmed">33352453</ArticleId></ArticleIdList></Reference><Reference><Citation>Drucker DJ. Diabetes, obesity, metabolism and SARS-CoV-2 infection: the end of the beginning. Cell Metab. 2021;33(3):479&#x2013;498. doi: 10.1016/j.cmet.2021.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.01.016</ArticleId><ArticleId IdType="pmc">PMC7825982</ArticleId><ArticleId IdType="pubmed">33529600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Bae JH, Kwon H-S, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11&#x2013;30. doi: 10.1038/s41574-020-00435-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00435-4</ArticleId><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>McCue C, Cowan R, Quasim T, Puxty K, McPeake J. Long term outcomes of critically ill COVID-19 pneumonia patients: early learning. Intensive Care Med. 2021;47(2):240&#x2013;241. doi: 10.1007/s00134-020-06313-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06313-x</ArticleId><ArticleId IdType="pmc">PMC7652047</ArticleId><ArticleId IdType="pubmed">33169214</ArticleId></ArticleIdList></Reference><Reference><Citation>EpiGear International . Ersatz Version 1.35 Brisbane, Australia: EpiGear International. 2017.</Citation></Reference><Reference><Citation>Australian Institute of Health and Welfare . The first year of COVID-19 in Australia: direct and indirect health effects: Australian Institute of Health and Welfare. 2021.</Citation></Reference><Reference><Citation>John D, Narassima MS, Menon J, Rajesh JG, Banerjee A. Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis. BMJ Open. 2021;11(8):e049619. doi: 10.1136/bmjopen-2021-049619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-049619</ArticleId><ArticleId IdType="pmc">PMC8375445</ArticleId><ArticleId IdType="pubmed">34408053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo MW, Go DS, Kim R, Lee SW, Ock M, Kim YE, et al. The burden of disease due to COVID-19 in Korea using disability-adjusted life years. J Korean Med Sci. 2020;35(21):e199-e. doi: 10.3346/jkms.2020.35.e199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e199</ArticleId><ArticleId IdType="pmc">PMC7261698</ArticleId><ArticleId IdType="pubmed">32476305</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurchis MC, Pascucci D, Sapienza M, Villani L, D'Ambrosio F, Castrini F, et al. Impact of the burden of COVID-19 in Italy: results of disability-adjusted life years (DALYs) and productivity loss. Int J Environ Res Public Health. 2020;17(12):4233. doi: 10.3390/ijerph17124233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17124233</ArticleId><ArticleId IdType="pmc">PMC7345321</ArticleId><ArticleId IdType="pubmed">32545827</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyper GMA, Fletcher E, Grant I, Harding O, de Haro Moro MT, Stockton DL, et al. Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland. Int J Equity Health. 2021;20(1):214. doi: 10.1186/s12939-021-01547-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-021-01547-7</ArticleId><ArticleId IdType="pmc">PMC8474788</ArticleId><ArticleId IdType="pubmed">34565406</ArticleId></ArticleIdList></Reference><Reference><Citation>Salinas-Escudero G, Toledano-Toledano F, Garc&#xed;a-Pe&#xf1;a C, Parra-Rodr&#xed;guez L, Granados-Garc&#xed;a V, Carrillo-Vega MF. Disability-adjusted life years for the COVID-19 pandemic in the Mexican population. Front Public Health. 2021;9:686700. doi: 10.3389/fpubh.2021.686700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.686700</ArticleId><ArticleId IdType="pmc">PMC8415975</ArticleId><ArticleId IdType="pubmed">34485216</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>